Randox Release: RX Series of Clinical Chemistry Analysers Provide Quality Results at Every Phase of Clinical Development

Crumlin, UK, 21 February 2011 -- Randox Pharma Services offers a comprehensive range of technologies and solutions, allowing Pharma Research and Development to become more efficient, cost effective and safer.

Amongst our extensive product portfolio is the RX Series of clinical chemistry analysers. All four analysers offer a world class test menu enabling you to avoid the costly outsourcing of routine safety testing, whilst allowing you to be in control of the entire process. We offer an analyser suited to each phase from pre-clinical through to high volume clinical trials, ensuring continuity and reliability throughout. The smallest of the series, the RX monza is a semi automated clinical analyser ideal for low throughput testing in clinical, research laboratories and specialised clinics. The RX daytona is a compact benchtop fully automated clinical analyser with a throughput of 180 photometric tests and 270 ISE tests per hour. The RX imola is a fully automated and random access benchtop analyser capable of performing 400 photometric tests and 240 ISE tests per hour. The latest addition to the RX Series is the RX suzuka. The RX suzuka is a fully automated random access analyser capable of carrying out up to 1200 tests per hour including ISEs, this system provides increased efficiency and productivity. With such wide choice, your requirements are sure to be met.

The RX Series offer a host of benefits in order to reduce costs, save time and make testing safer. Each system requires only a small sample volume which conserves valuable sample. Reagent volume required is also low, reducing cost per test. The RX Series require no extra consumables, for example; permanent pyrex cuvettes are used, providing considerable cost savings. To complete the package, we also provide an unrivalled Quality Control package. Randox quality controls cover over 170 parameters and are known to be of the highest quality and the most accurate, stable and consistent controls available, ensuring valid clinical results. Customised QC is also available in addition to RIQAS, the largest global EQA scheme.

In addition to the RX Series and QC package, Randox Pharma Services also offer an extensive test menu consisting of over 120 enzymatic, substrate and immunoturbidimetric assays. With nearly 30 years of experience providing world leading innovative products, our reagents are of the highest quality and are ISO13485 and FDA compliant. Our test menu includes the following markers;

Routine biochemistry

Cardiac

Liver

Kidney

Autoimmune

Lipid

Haematology

Diabetes

Prostate

Thyroid

Fertility

Bone

Veterinary

Therapeutic drugs

Drugs of abuse

Not only is our test menu extensive and continually expanding, the methods used are world class. For example our HDL and LDL tests use a superior clearance method. This ensures you can have confidence in results.

For more information please visit www.randoxpharmaservices.com or contact us at pharmaservices@randox.com.

About Randox Pharma Services

In recognition of the vital role biomarkers play in drug development programmes, Randox Pharma Services offer a comprehensive range of solutions, allowing Pharma R&D to become more efficient, cost effective and safer. Biochip Array Technology, a revolutionary multiplexing technology, enables multiple biomarker results from a single sample. Over 120 enzymatic, substrate and immunoturbidimetric assays are available for use on our range of world class clinical chemistry analysers while our QC range provides essential performance checks and traceability. We can even provide a tailor made solution to fulfil your requirements. Randox Pharma Services support every stage of the clinical trial process.

Back to news